Association of radioactive iodine treatment with survivorship symptoms and primary care utilisation in women of reproductive age with thyroid cancer: a retrospective cohort study
{{output}}
Objectives: Radioactive iodine (RAI) is commonly administered after thyroid cancer surgery and is generally considered low risk. Its use in women of reproductive age, however, is increasingly debated. Most research has focused on... ...
